4//SEC Filing
Patel Sushil 4
Accession 0001610717-24-000205
CIK 0001628171other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 4:23 PM ET
Size
8.4 KB
Accession
0001610717-24-000205
Insider Transaction Report
Form 4
Patel Sushil
Director
Transactions
- Exercise/Conversion
Common Stock
2024-04-10$16.80/sh+2,155$36,204→ 17,855 total - Sale
Common Stock
2024-04-10$37.00/sh−2,155$79,735→ 15,700 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-04-10−2,155→ 34,645 totalExercise: $16.80Exp: 2032-06-15→ Common Stock (2,155 underlying)
Footnotes (3)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on September 7, 2023.
- [F2]Includes 10,450 restricted stock units.
- [F3]The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of June 16, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001860609
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 4:23 PM ET
- Size
- 8.4 KB